Phage-based molecular directed evolution yields multiple tandem human IgA affibodies with intramolecular binding avidity.

[1]  Xiaoning Wang,et al.  Alternate arrangement of PpL B3 domain and SpA D domain creates synergistic double-site binding to VH3 and Vkappa regions of fab. , 2008, DNA and cell biology.

[2]  P. Nygren,et al.  Alternative binding proteins: Affibody binding proteins developed from a small three‐helix bundle scaffold , 2008, The FEBS journal.

[3]  E. Feil,et al.  S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. , 2008, Molecular immunology.

[4]  A. Skerra.  Alternative non-antibody scaffolds for molecular recognition. , 2007, Current opinion in biotechnology.

[5]  Heinrich Leonhardt,et al.  Targeting and tracing antigens in live cells with fluorescent nanobodies , 2006, Nature Methods.

[6]  A. Wieczorek,et al.  The NH2-terminal php Domain of the α Subunit of the Escherichia coli Replicase Binds the ϵ Proofreading Subunit* , 2006, Journal of Biological Chemistry.

[7]  G. Adams,et al.  Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  W. Stemmer,et al.  Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains , 2005, Nature Biotechnology.

[9]  P. Hudson,et al.  Engineered antibody fragments and the rise of single domains , 2005, Nature Biotechnology.

[10]  A. Plückthun,et al.  High-affinity binders selected from designed ankyrin repeat protein libraries , 2004, Nature Biotechnology.

[11]  P. Zhao,et al.  Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81 , 2003, Cell Research.

[12]  M. Uhlén,et al.  Human immunoglobulin A (IgA)-specific ligands from combinatorial engineering of protein A. , 2002, European journal of biochemistry.

[13]  G. Lindahl,et al.  Streptococcal IgA-binding Proteins Bind in the Cα2-Cα3 Interdomain Region and Inhibit Binding of IgA to Human CD89* , 2001, The Journal of Biological Chemistry.

[14]  M. Taussig,et al.  Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Delano,et al.  Convergent solutions to binding at a protein-protein interface. , 2000, Science.

[16]  M. Uhlén,et al.  Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain , 1997, Nature Biotechnology.

[17]  L. Björck,et al.  Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. , 1992, The Journal of biological chemistry.

[18]  P. Alexander,et al.  Gene for an immunoglobulin-binding protein from a group G streptococcus , 1986, Journal of bacteriology.

[19]  M. Uhlén,et al.  Staphylococcal protein A consists of five IgG-binding domains. , 1986, European journal of biochemistry.

[20]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[21]  A. Koide,et al.  Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain. , 2007, Methods in molecular biology.

[22]  Arne Skerra,et al.  Lipocalins in drug discovery: from natural ligand-binding proteins to "anticalins". , 2005, Drug discovery today.